Semler Scientific, Inc. (SMLR)
USD 36.16
(8.49%)
USD 36.16
(8.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 70 Thousand USD | -71.43% |
| 2022 | 245 Thousand USD | -24.62% |
| 2021 | 325 Thousand USD | -2.11% |
| 2020 | 332 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 2.92 Million USD | 11.86% |
| 2016 | 2.61 Million USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 2 Million USD | 640.74% |
| 2013 | 270 Thousand USD | -27.61% |
| 2012 | 373 Thousand USD | -20.97% |
| 2011 | 472 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 116 Thousand USD | -15.94% |
| 2024 Q1 | 138 Thousand USD | 97.14% |
| 2024 Q3 | - USD | -25.0% |
| 2023 FY | 70 Thousand USD | -71.43% |
| 2023 Q2 | 203 Thousand USD | -9.38% |
| 2023 Q3 | 181 Thousand USD | -10.84% |
| 2023 Q4 | 70 Thousand USD | -61.33% |
| 2023 Q1 | 224 Thousand USD | -8.57% |
| 2022 Q2 | 285 Thousand USD | -6.56% |
| 2022 Q1 | 305 Thousand USD | -6.15% |
| 2022 Q4 | 245 Thousand USD | -7.89% |
| 2022 FY | 245 Thousand USD | -24.62% |
| 2022 Q3 | 266 Thousand USD | -6.67% |
| 2021 Q3 | 345 Thousand USD | -5.22% |
| 2021 Q1 | 382 Thousand USD | 15.06% |
| 2021 FY | 325 Thousand USD | -2.11% |
| 2021 Q2 | 364 Thousand USD | -4.71% |
| 2021 Q4 | 325 Thousand USD | -5.8% |
| 2020 Q4 | 332 Thousand USD | -3.77% |
| 2020 FY | 332 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q2 | 5000.00 USD | 0.0% |
| 2020 Q3 | 345 Thousand USD | 6800.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 Q4 | - USD | -100.0% |
| 2018 Q1 | 2.26 Million USD | -22.61% |
| 2018 Q2 | 2.06 Million USD | -8.62% |
| 2018 Q3 | 1.83 Million USD | -11.08% |
| 2018 FY | - USD | -100.0% |
| 2017 Q3 | 2.87 Million USD | 3.49% |
| 2017 Q1 | 2.63 Million USD | 0.77% |
| 2017 FY | 2.92 Million USD | 11.86% |
| 2017 Q4 | 2.92 Million USD | 1.53% |
| 2017 Q2 | 2.78 Million USD | 5.66% |
| 2016 Q2 | 2.18 Million USD | 15.68% |
| 2016 FY | 2.61 Million USD | 0.0% |
| 2016 Q4 | 2.61 Million USD | 12.24% |
| 2016 Q1 | 1.88 Million USD | 0.0% |
| 2016 Q3 | 2.32 Million USD | 6.59% |
| 2015 FY | - USD | -100.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q2 | 2 Million USD | 0.0% |
| 2015 Q1 | 2 Million USD | 0.0% |
| 2014 Q4 | 2 Million USD | 1669.91% |
| 2014 Q2 | 217 Thousand USD | -10.7% |
| 2014 Q3 | 113 Thousand USD | -47.93% |
| 2014 FY | 2 Million USD | 640.74% |
| 2014 Q1 | 243 Thousand USD | -10.0% |
| 2013 FY | 270 Thousand USD | -27.61% |
| 2013 Q2 | 864.99 Thousand USD | -29.45% |
| 2013 Q3 | 296 Thousand USD | -65.78% |
| 2013 Q4 | 270 Thousand USD | -8.78% |
| 2013 Q1 | 1.22 Million USD | 228.69% |
| 2012 Q4 | 373 Thousand USD | 0.0% |
| 2012 FY | 373 Thousand USD | -20.97% |
| 2011 FY | 472 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| electroCore, Inc. | 626 Thousand USD | 88.818% |
| NeuroPace, Inc. | 72.39 Million USD | 99.903% |
| Sight Sciences, Inc. | 35.41 Million USD | 99.802% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | 95.611% |
| SI-BONE, Inc. | 38.99 Million USD | 99.82% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 99.759% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 99.822% |
| Cerus Corporation | 95.99 Million USD | 99.927% |
| Axonics, Inc. | 27.61 Million USD | 99.747% |
| 908 Devices Inc. | 5.94 Million USD | 98.823% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 99.9% |
| TELA Bio, Inc. | 42.78 Million USD | 99.836% |
| Venus Concept Inc. | 79.69 Million USD | 99.912% |
| Tivic Health Systems, Inc. | 369 Thousand USD | 81.03% |
| RxSight, Inc. | 3.01 Million USD | 97.676% |
| LENSAR, Inc. | 2.3 Million USD | 96.968% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 99.047% |
| LivaNova PLC | 640.4 Million USD | 99.989% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 97.019% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 99.541% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.987% |
| Apyx Medical Corporation | 38.5 Million USD | 99.818% |
| Cutera, Inc. | 431.91 Million USD | 99.984% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 99.552% |
| BioSig Technologies, Inc. | 452 Thousand USD | 84.513% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.996% |
| Bioventus Inc. | 409.47 Million USD | 99.983% |
| Envoy Medical, Inc. | 404 Thousand USD | 82.673% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -22.807% |
| Outset Medical, Inc. | 136.18 Million USD | 99.949% |
| Nexalin Technology, Inc. | 4463.00 USD | -1468.452% |
| IRIDEX Corporation | 2.74 Million USD | 97.451% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 99.912% |
| IRadimed Corporation | 2.04 Million USD | 96.574% |
| PAVmed Inc | 48.72 Million USD | 99.856% |
| INVO Bioscience, Inc. | 8.68 Million USD | 99.194% |
| Movano Inc. | 252 Thousand USD | 72.222% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 99.789% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | 62.039% |
| Spectral AI, Inc. | 1.28 Million USD | 94.569% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 99.318% |
| Varex Imaging Corporation | 469.5 Million USD | 99.985% |
| Quipt Home Medical Corp. | 98.94 Million USD | 99.929% |
| IceCure Medical Ltd | 599 Thousand USD | 88.314% |
| Pulmonx Corporation | 41.42 Million USD | 99.831% |
| Modular Medical, Inc. | 1.19 Million USD | 94.118% |
| ReShape Lifesciences Inc. | 262 Thousand USD | 73.282% |
| Insulet Corporation | 1.44 Billion USD | 99.995% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 99.498% |
| Orthofix Medical Inc. | 134.19 Million USD | 99.948% |
| InMode Ltd. | 9.01 Million USD | 99.224% |
| Bruker Corporation | 1.37 Billion USD | 99.995% |
| Surmodics, Inc. | 29.4 Million USD | 99.762% |
| Cytosorbents Corporation | 18.31 Million USD | 99.618% |
| iCAD, Inc. | 461 Thousand USD | 84.816% |
| DexCom, Inc. | 2.59 Billion USD | 99.997% |
| Align Technology, Inc. | 96.96 Million USD | 99.928% |
| ZimVie Inc. | 521.92 Million USD | 99.987% |
| Nexalin Technology, Inc. | 4463.00 USD | -1468.452% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 96.494% |
| BrainsWay Ltd. | 471 Thousand USD | 85.138% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.983% |
| Profound Medical Corp. | 7.9 Million USD | 99.114% |
| enVVeno Medical Corporation | 1.4 Million USD | 95.007% |
| Nuwellis, Inc. | 981 Thousand USD | 92.864% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 99.166% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | 92.556% |
| Inogen, Inc. | 21.92 Million USD | 99.681% |
| MaxCyte, Inc. | 18.74 Million USD | 99.627% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 99.946% |
| OrthoPediatrics Corp. | 23.76 Million USD | 99.705% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | 96.494% |
| InspireMD, Inc. | 1.59 Million USD | 95.611% |
| PAVmed Inc. | 48.72 Million USD | 99.856% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | 85.772% |
| BIOLASE, Inc. | 17.91 Million USD | 99.609% |
| Beyond Air, Inc. | 17.83 Million USD | 99.608% |
| FONAR Corporation | 41.67 Million USD | 99.832% |
| AxoGen, Inc. | 69.29 Million USD | 99.899% |
| Vivani Medical, Inc. | 20.69 Million USD | 99.662% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 99.861% |
| Inari Medical, Inc. | 32.04 Million USD | 99.782% |
| UFP Technologies, Inc. | 46.03 Million USD | 99.848% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 97.721% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | 93.245% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 97.659% |
| Tenon Medical, Inc. | 1.17 Million USD | 94.032% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 93.014% |
| CVRx, Inc. | 30.61 Million USD | 99.771% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.997% |
| Sintx Technologies, Inc. | 4.24 Million USD | 98.351% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | 96.491% |
| NanoVibronix, Inc. | 5000.00 USD | -1300.0% |
| Quanterix Corporation | 41.46 Million USD | 99.831% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 97.019% |
| Sensus Healthcare, Inc. | 783 Thousand USD | 91.06% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.993% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.986% |
| ReWalk Robotics Ltd. | 1.9 Million USD | 96.322% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | 70.939% |
| Hyperfine, Inc. | 185 Thousand USD | 62.162% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 99.964% |
| Biomerica, Inc. | 785 Thousand USD | 91.083% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 84.427% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | 81.086% |
| Silk Road Medical, Inc | 84.63 Million USD | 99.917% |